Devices shine in Cleveland Clinic’s “Top 10”
This article was originally published in The Gray Sheet
Executive Summary
Neurostimulation for psychiatric disorders comes in at No. 3 on Cleveland Clinic's list of medical innovations likely to have a significant impact on healthcare in 2007, unveiled Nov. 7 at the institution's 2006 Medical Innovations Summit. Center for Neurology Restoration Chair Ali Rezai, MD, notes that mental disorders account for 15% of the disease burden in the U.S. - more than all cancers combined - and four of the ten leading causes of disability in developed countries. Developers include Medtronic, investigating the use of deep brain stimulation to treat depression and obsessive compulsive disorder (1"The Gray Sheet" May 22, 2006, p. 7). Non-pulsatile left ventricular assist devices also made the list (No. 9), while the 4, 5 and 7 spots went to optical coherence tomography for treating and diagnosing eye diseases, bronchial thermoplasty for treating asthma, and endografting for treating vascular disease, respectively. The other top spots went to drugs...